Measurement of intima-media thickness vs. carotid plaque: Uses in patient care, genetic research and evaluation of new therapies

International Journal of Stroke

Volumn 1, Issue 4, 2006, Pages 216-221

  Spence, David ^a  

^a Stroke Prevention and Atherosclerosis Research Centre   (Canada)

Author keywords

3 D Ultrasound; Carotid; IMT; Intima Media Thickness; Plaque Area; Plaque Volume; Ultrasound

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PLACEBO;

ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CAROTID ARTERY DISEASE; DIET RESTRICTION; DISEASE COURSE; DRUG UTILIZATION; ECHOGRAPHY; EXERCISE; GENETIC DIFFERENCE; HUMAN; MOTIVATION; PATIENT CARE; PATIENT COMPLIANCE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING CESSATION; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME;

CAROTID ARTERY DISEASES; HUMANS; TUNICA INTIMA; TUNICA MEDIA;

EID: 33749624864     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2006.00068.x     Document Type: Review

References (45)

1. Bond MG, Wilmoth SK, Gardin JF, Barnes RW, Sawyer JK: Noninvasive assessment of atherosclerosis in nonhuman primates. Adv Exp Med Biol 1985; 183:189-95.
2. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R: Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation 1986; 74:1399-406.
3. Barnett PA, Spence JD, Manuck SB, Jennings JR: Psychological stress and the progression of carotid atherosclerosis. J Hypertension 1997; 15:49-55.
4. Touboul P-J, Labreuche J, Vicaut E, Amarenco P: Carotid intima-media thickness, plaques, and framingham risk score as independent determinants of stroke risk. Stroke 2005; 36:1748-52.
5. Spence JD, Eliasziw M, DiCicco M, Hackam DG, Galil R, Lohmann T: Carotid plaque area: A tool for targeting and evaluating vascular preventive therapy. Stroke 2002; 33:2916-22.
6. SUence JD: Point: uses of carotid plaque measurement as a predictor of cardiovascular events. Prev Cardiol 2005; 8:118-21.
7. Spence JD, Barnett PA, Bulman DE, Hegele RA: An approach to ascertain probands with a non traditional risk factor for carotid atherosclerosis. Atherosclerosis 1999; 144:429-34.
8. Ranke C, Hecker H, Creutzig A et al. Dose-dependent effect of aspirin on carotid atherosclerosis. Circulation 1993; 87:1873-9.
9. Wiesli P, Czerwenka W, Meniconi A et al. Roxithromycin treatment prevents progression peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men a randomized, double-blind, placebo-controlled trial. Circulation 2002; 105:2646-52.
10. Mancini GB, Abbott D, Kamimura C, Yeoh E: Validation of a new ultrasound method for the measurement of carotid artery intima medial thickness and plaque dimensions. Can J Cardiol 2004; 20:1355-9.
11. Fenster A, Downey DB: Three-dimensional ultrasound imaging and its use in quantifying organ and pathology volumes. Ann Bioanal Chem 2003; 377:982-9.
12. Picot PA, Rickey DW, Mitchell R, Rankin R, Fenster A: Three-dimensional colour Doppler imaging of the carotid artery. SPIE Med Imag 1991; 1444:206-13.
13. Fenster A, Landry A, Downey DB, Hegele RA, Spence JD: 3D ultrasound imaging of the carotid arteries. Curr Drug Targets -Cardiovasc Hematol Disorders 2004; 4:161-75.
14. Landry A, Fenster A: Theoretical and experimental quantification of carotid plaque volume measurements made by three-dimensional ultrasound using test phantoms. Med Phys 2002; 29:2319-27.
15. Landry A, Spence JD, Fenster A: Quantification of carotid plaque volume measurements using 3D ultrasound imaging. Ultrasound Med Biol 2005; 31:751-62.
16. Landry A, Spence JD, Fenster A: Measurement of carotid plaque volume by 3-dimensional ultrasound. Stroke 2004; 35:864-9.
17. Stork S, Feelders RA, van den Beld AW et al. Prediction of mortality risk in the elderly. Am J Med 2006; 119:519-25.
18. O'Leary DH, Polak JF, Kronmal RA et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340:14-22.
19. Tartière J-M, Henry OF, Safar H et al. Carotid intima-media thickness and carotid and/or iliofemoral plaques: Comparison of two markers of cardiovascular risk in hypertensive patients. J Hypertension 2003; 21:739-46.
20. Baldassarre D, Amato M, Pustina L et al. Measurement of carotid artery intima-media thickness in dyslipidemic patients increases the power of traditional risk factors to predict cardiovascular events. Atherosclerosis 2006 May 6; [Epub ahead of print]:PMID: 16682042.
21. Chan SY, Mancini GB, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A: The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 2003; 42:1037-43.
22. Brook RD, Bard RL, Patel S et al. A negative carotid plaque area test is superior to other non-invasive atherosclerosis studies for reducing the likelihood of having significant coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26:656-62.
23. Touboul PJ, Hennerici MG, Meairs S et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis 2004; 18:346-9.
24. Robertson J, Iemolo F, Stabler SP, Allen RH, Spence JD: Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products. Can Med Assoc J 2005; 172:1569-73.
25. Spence JD: Ultrasound measurement ofUcarotid plaque: uses in patient management, genetic research and evaluation of new therapies. Nat Clin Pract Neurol 2006, In press.
26. Clarkson TB, Prichard RW, Morgan TM, Petrick GS, Klein KP: Remodelling of coronary arteries in human and nonhuman primates. JAMA 1994; 271:289-94.
27. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316:1371-5.
28. Spence JD: Advances in Ntherosclerosis: new understanding based on endothelial function; in Fisher M, Bogousslavsky J (eds): Current Review of Cerebrovascular Disease, 3rd edn. Philadelphia: Current Medicine, 1999: 1-13.
29. Adams MR, Nakagomi A, Keech A et al. Carotid intimal-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation 1995; 92:2127-34.
30. Ebrahim SB, Papacosta O, Whincup P et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: The British regional heart study. Stroke 1999; 30:841-50.
31. Aminbakhsh A, Frohlich J, Mancini GBJ: Detection of early atherosclerosis with B mode Ultrasonography: Assessment of a new quantitative approach. Clin Invest Med 1999; 22:265-74.
32. Al Shali K, House AA, Hanley AJ et al. Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions. Atherosclerosis 2005 Feb; 178:319-25.
33. Humphries SE, Morgan L: Genetic risk factors for stroke and carotid atherosclerosis: Insights into pathophysiology from candidate gene approaches. Lancet Neurol 2004; 3:227-36.
34. Pollex RL, Hegele RA: Genetic determinants of carotid ultrasound traits. Curr Atheroscler Rep 2006; 8:206-15.
35. Al Shali KZ, House AA, Hanley AJ et al. Genetic variation in PPARG encoding peroxisome proliferator-activated receptor gamma associated with carotid atherosclerosis. Stroke 2004; 35:2036-40.
36. Hegele RA, Al-Shali KZ, House AA et al. Disparate associations of a functional promoter polymorphism in PCK1 with carotid wall ultrasound traits. Stroke 2005; 36:2566-70.
37. Spence JD, Hegele RA: Noninvasive phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24:e188-9.
38. O'Leary DH, Polak JF, Kronmal RA et al. Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular health study collaborative research group. Stroke 1996; 27:224-31.
39. Spence JD, Hegele RA: Noninvasive pheSotypes of atherosclerosis: similar windows but different views. Stroke 2004 Mar; 35:649-53.
40. Spence JD, Hegele RA: Noninvasive phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24:e188-9.
41. Bots ML, Evans GW, Riley WA, Grobbee DE: Carotid intima-media thickness measurements in intervention studies: Design options, progression rates, and sample size considerations. a point of view. Stroke 2003; 34:2985-94.
42. Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD: 3D ultrasound measurement of change in carotid plaque volume: A tool for rapid evaluation of new therapies. Stroke 2005; 36:1904-9.
43. Corti R, Fuster V, Fayad ZA et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: A prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol 2005; 46:106-12.
44. Nissen SE, Tuzcu EM, Schoenhagen P et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 2004; 291:1071-80.
45. Wendelhag I, Wiklund O, Wikstrand J: On quantifying plaque size and intima-media thickness in carotid and femoral arteries. Comments on results from a prospective ultrasound study in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 1996; 16:843-50.